Canada Pension Plan Investment Board lifted its position in shares of Davita Inc (NYSE:DVA) by 38.9% during the 4th quarter, Holdings Channel reports. The firm owned 343,483 shares of the company’s stock after buying an additional 96,169 shares during the quarter. Canada Pension Plan Investment Board’s holdings in Davita were worth $17,674,000 at the end of the most recent quarter.
Other large investors have also recently added to or reduced their stakes in the company. Quantamental Technologies LLC bought a new stake in shares of Davita during the fourth quarter worth about $34,000. Oregon Public Employees Retirement Fund grew its holdings in shares of Davita by 4,995.1% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 1,880,451 shares of the company’s stock worth $37,000 after purchasing an additional 1,843,544 shares during the last quarter. Dupont Capital Management Corp grew its holdings in shares of Davita by 41.0% during the fourth quarter. Dupont Capital Management Corp now owns 2,525 shares of the company’s stock worth $130,000 after purchasing an additional 734 shares during the last quarter. Honkamp Krueger Financial Services Inc. acquired a new position in shares of Davita in the third quarter worth approximately $143,000. Finally, Caption Management LLC lifted its stake in shares of Davita by 100.7% in the fourth quarter. Caption Management LLC now owns 3,200 shares of the company’s stock worth $164,000 after acquiring an additional 488,800 shares during the period. Institutional investors own 85.00% of the company’s stock.
Davita stock opened at $59.21 on Friday. The company has a current ratio of 1.72, a quick ratio of 1.70 and a debt-to-equity ratio of 2.09. The company has a market capitalization of $9.80 billion, a P/E ratio of 16.59, a P/E/G ratio of 0.59 and a beta of 1.31. Davita Inc has a one year low of $48.25 and a one year high of $79.11.
Davita (NYSE:DVA) last posted its quarterly earnings data on Wednesday, February 13th. The company reported $0.90 EPS for the quarter, topping the Zacks’ consensus estimate of $0.89 by $0.01. Davita had a return on equity of 14.17% and a net margin of 1.40%. The company had revenue of $2.82 billion for the quarter, compared to analyst estimates of $2.97 billion. During the same period in the previous year, the firm earned $0.92 earnings per share. The firm’s quarterly revenue was up 1.4% on a year-over-year basis. Equities analysts predict that Davita Inc will post 4.42 earnings per share for the current fiscal year.
A number of research firms recently commented on DVA. Raymond James lowered Davita from a “strong-buy” rating to a “market perform” rating in a research note on Thursday, November 8th. TheStreet lowered Davita from a “b-” rating to a “c+” rating in a research note on Thursday, November 8th. Royal Bank of Canada lifted their price objective on Davita from $70.00 to $78.00 and gave the stock a “sector perform” rating in a research note on Thursday, November 8th. Zacks Investment Research lowered Davita from a “hold” rating to a “sell” rating in a research note on Tuesday, November 13th. Finally, UBS Group began coverage on Davita in a research note on Thursday, November 15th. They issued a “sell” rating and a $64.00 price objective on the stock. One analyst has rated the stock with a sell rating, six have assigned a hold rating and four have assigned a buy rating to the stock. The company presently has an average rating of “Hold” and an average price target of $66.92.
COPYRIGHT VIOLATION WARNING: “Canada Pension Plan Investment Board Grows Stake in Davita Inc (DVA)” was reported by Zolmax and is the property of of Zolmax. If you are accessing this article on another publication, it was copied illegally and republished in violation of US and international copyright and trademark legislation. The legal version of this article can be viewed at https://zolmax.com/investing/canada-pension-plan-investment-board-grows-stake-in-davita-inc-dva/2918564.html.
DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
Read More: Discover Your Risk Tolerance
Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Davita Inc (NYSE:DVA).
Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.